The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans

FEBS Journal

Volumn 281, Issue 3, 2014, Pages 739-749

  Norheim, Frode ^a   Langleite, Torgrim Mikal ^a   Hjorth, Marit ^a   Holen, Torgeir ^a   Kielland, Anders ^a   Stadheim, Hans Kristian ^b   Gulseth, Hanne Løvdal ^c   Birkeland, Kåre Inge ^c,d   Jensen, Jørgen ^b   Drevon, Christian A ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN SCHOOL OF SPORT SCIENCES   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Exercise; FNDC5; Irisin; PGC 1 ; UCP1

Indexed keywords

FIBRONECTIN; IRISIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1;

ADULT; AGED; ARTICLE; BROWN ADIPOSE TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDURANCE TRAINING; EXERCISE; FNDC5 GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; MALE; OBESITY; PGC1A GENE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESISTANCE TRAINING; SKELETAL MUSCLE; SUBCUTANEOUS FAT; UCP1 GENE;

MURINAE;

EXERCISE; FNDC5; IRISIN; PGC-1Α; UCP1;

ADULT; AGED; BODY MASS INDEX; EXERCISE; FIBRONECTINS; HUMANS; ION CHANNELS; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; MOTOR ACTIVITY; MUSCLE, SKELETAL; OVERWEIGHT; PHYSICAL ENDURANCE; PIGMENTS, BIOLOGICAL; PREDIABETIC STATE; RESISTANCE TRAINING; RNA, MESSENGER; SUBCUTANEOUS FAT, ABDOMINAL; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84895086158     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12619     Document Type: Article

References (42)

1. (2008) Physical Activity Guidelines Advisory Committee report, 2008. To the Secretary of Health and Human Services. Part A: Executive summary. Nutr Rev 67, 114-120.
2. Thompson PD (2003) Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease. Arterioscler Thromb Vasc Biol 23, 1319-1321.
3. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA & Nathan DM (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346, 393-403.
4. Coughlin K (2007) A global perspective on cancer prevention. Br J Nurs 16, 1252.
5. Martinsen EW (1994) Physical activity and depression: clinical experience. Acta Psychiatr Scand Suppl 377, 23-27.
6. Gass M & Dawson-Hughes B (2006) Preventing osteoporosis-related fractures: an overview. Am J Med 119, S3-S11.
7. Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, Chasan-Taber L, Albright AL & Braun B (2010) Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care 33, 2692-2696.
8. Pedersen BK & Febbraio MA (2012) Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 8, 457-465.
9. Egan B & Zierath JR (2013) Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab 17, 162-184.
10. Hood DA, Irrcher I, Ljubicic V & Joseph AM (2006) Coordination of metabolic plasticity in skeletal muscle. J Exp Biol 209, 2265-2275.
11. Pilegaard H, Saltin B & Neufer PD (2003) Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle. J Physiol 546, 851-858.
12. Ruas JL, White JP, Rao RR, Kleiner S, Brannan KT, Harrison BC, Greene NP, Wu J, Estall JL, Irving BA et al. (2012) A PGC-1alpha isoform induced by resistance training regulates skeletal muscle hypertrophy. Cell 151, 1319-1331.
13. Short KR, Vittone JL, Bigelow ML, Proctor DN, Rizza RA, Coenen-Schimke JM & Nair KS (2003) Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 52, 1888-1896.
14. Handschin C & Spiegelman BM (1924) The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 454, 463-469.
15. Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, Cooper M, Laznik D, Chinsomboon J, Rangwala SM et al. (1921) HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature 451, 1008-1012.
16. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN et al. (2002) Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418, 797-801.
17. Lin J, Handschin C & Spiegelman BM (2005) Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1, 361-370.
18. Ouellet V, Labbe SM, Blondin DP, Phoenix S, Guerin B, Haman F, Turcotte EE, Richard D & Carpentier AC (2012) Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. J Clin Invest 122, 545-552.
19. Saito M, Okamatsu-Ogura Y, Matsushita M, Watanabe K, Yoneshiro T, Nio-Kobayashi J, Iwanaga T, Miyagawa M, Kameya T, Nakada K et al. (2009) High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 58, 1526-1531.
20. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM, Kemerink GJ, Bouvy ND, Schrauwen P & Teule GJ (2009) Cold-activated brown adipose tissue in healthy men. N Engl J Med 360, 1500-1508.
21. Cannon B & Nedergaard J (2012) Yes, even human brown fat is on fire!. J Clin Invest 122, 486-489.
22. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, Tseng YH, Doria A et al. (2009) Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360, 1509-1517.
23. Petrovic N, Walden TB, Shabalina IG, Timmons JA, Cannon B & Nedergaard J (2010) Chronic peroxisome proliferator-activated receptor gamma (PPARgamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes. J Biol Chem 285, 7153-7164.
24. Seale P, Conroe HM, Estall J, Kajimura S, Frontini A, Ishibashi J, Cohen P, Cinti S & Spiegelman BM (2011) Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. J Clin Invest 121, 96-105.
25. Wu J, Bostrom P, Sparks LM, Ye L, Choi JH, Giang AH, Khandekar M, Virtanen KA, Nuutila P, Schaart G et al. (2012) Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150, 366-376.
26. Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Bostrom EA, Choi JH, Long JZ et al. (2012) A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481, 463-468.
27. Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE & Mantzoros CS (2012) FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 61, 1725-1738.
28. Timmons JA, Baar K, Davidsen PK & Atherton PJ (2012) Is irisin a human exercise gene? Nature 488, E9-E10.
29. Pekkala S, Wiklund PK, Hulmi JJ, Ahtiainen JP, Horttanainen M, Pollanen E, Makela KA, Kainulainen H, Hakkinen K, Nyman K et al. (2013) Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health? J Physiol 591, 5393-5400.
30. Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, Ricart W & Fernandez-Real JM (2013) Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 98, E769-E778.
31. Park KH, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, Joung KE, Tsoukas M, Geladari EV, Young HJ, Dincer F et al. (2013) Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab, in press.
32. Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P & Klapp BF (2013) Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with body mass index. Peptides 39, 125-130.
33. Wen MS, Wang CY, Lin SL & Hung KC (2013) Decrease in irisin in patients with chronic kidney disease. PLoS ONE 8, e64025.
34. Raschke S, Elsen M, Gassenhuber H, Sommerfeld M, Schwahn U, Brockmann B, Jung R, Wisloff U, Tjonna AE, Raastad T et al. (2013) Evidence against a beneficial effect of irisin in humans. PLoS ONE 8, e73680.
35. Mukwevho E, Kohn TA, Lang D, Nyatia E, Smith J & Ojuka EO (2008) Caffeine induces hyperacetylation of histones at the MEF2 site on the Glut4 promoter and increases MEF2A binding to the site via a CaMK dependent mechanism. Am J Physiol Endocrinol Metab 294, E582-E588.
36. Erickson HP (2013) Irisin and FNDC5 in retrospect: an exercise hormone or a transmembrane receptor? Adipocyte 2, 289-293.
37. Staiger H, Bohm A, Scheler M, Berti L, Machann J, Schick F, Machicao F, Fritsche A, Stefan N, Weigert C et al. (2013) Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived 'browning' factor irisin, determines insulin sensitivity. PLoS ONE 8, e61903.
38. Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, Lee WK, Kim JG, Lee IK & Park KG (2013) Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract 100, 96-101.
39. Lidell ME, Betz MJ, Dahlqvist LO, Heglind M, Elander L, Slawik M, Mussack T, Nilsson D, Romu T, Nuutila P et al. (2013) Evidence for two types of brown adipose tissue in humans. Nat Med 19, 631-634.
40. Jespersen NZ, Larsen TJ, Peijs L, Daugaard S, Homoe P, Loft A, de Jong J, Mathur N, Cannon B, Nedergaard J et al. (2013) A classical brown adipose tissue mRNA signature partly overlaps with brite in the supraclavicular region of adult humans. Cell Metab 17, 798-805.
41. Lecker SH, Zavin A, Cao P, Arena R, Allsup K, Daniels KM, Joseph J, Schulze PC & Forman DE (2012) Expression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure. Circ Heart Fail 5, 812-818.
42. Haugen F, Norheim F, Lian H, Wensaas AJ, Dueland S, Berg O, Funderud A, Skalhegg BS, Raastad T & Drevon CA (2010) IL-7 is expressed and secreted by human skeletal muscle cells. Am J Physiol Cell Physiol 298, C807-C816.